SFMG Wealth Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$405K Sell
1,834
-84
-4% -$23.2K 0.02% 220
2026
Q1
$566K Buy
1,918
+24
+1% +$7.13K 0.04% 171
2025
Q4
$517K Sell
1,894
-11
-0.6% -$2.99K 0.03% 183
2025
Q3
$515K Buy
1,905
+12
+0.6% +$3.27K 0.04% 171
2025
Q2
$522K Buy
1,893
+6
+0.3% +$1.63K 0.04% 154
2025
Q1
$500K Buy
1,887
+57
+3% +$14.1K 0.04% 149
2024
Q4
$425K Sell
1,830
-3
-0.2% -$690 0.03% 167
2024
Q3
$405K Buy
1,833
+1
+0.1% +$207 0.03% 169
2024
Q2
$360K Sell
1,832
-93
-5% -$19.2K 0.03% 173
2024
Q1
$414K Buy
1,925
+29
+2% +$6.09K 0.04% 164
2023
Q4
$399K Buy
1,896
+11
+0.6% +$2.35K 0.04% 163
2023
Q3
$377K Buy
+1,885
New +$375K 0.04% 158
2023
Q2
Sell
-1,354
Closed -$259K 260
2023
Q1
$259K Buy
+1,354
New +$245K 0.03% 200
2022
Q2
Sell
-920
Closed -$219K 285
2022
Q1
$219K Buy
+920
New +$216K 0.02% 257

Other funds holding CME

SFMG Wealth Advisors's CME Position: Q2 2026 in Review

SFMG Wealth Advisors reduced its CME Group (CME) stake by 4.4% in Q2 2026, selling an estimated $23.2K and leaving 1,834 shares worth $405K. The position accounts for 0.02% of the portfolio, ranked #220.

SFMG Wealth Advisors first reported a position in CME in Q1 2022 and has held it in 14 quarters since. The position peaked at $566K in Q1 2026. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • SFMG Wealth Advisors held 1,834 shares of CME Group worth $405K as of Q2 2026.
  • SFMG Wealth Advisors sold 84 CME Group shares in Q2 2026, an estimated $23.2K.
  • CME Group made up 0.02% of SFMG Wealth Advisors's portfolio in Q2 2026, its #220 holding.
  • SFMG Wealth Advisors first reported a position in CME Group in Q1 2022 and has held it in 14 quarters since.
  • SFMG Wealth Advisors's CME Group position peaked at $566K in Q1 2026.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on SFMG Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.